DrAid™: PIONEERING PRODUCT REVOLUTIONIZING LIVER CANCER DIAGNOSIS WITH AI

DrAid™ CT Liver Cancer was first introduced and garnered significant attention from leading experts in AI and healthcare at the 4th annual AI and Medical Imaging Symposium held at Stanford University School of Medicine, California, USA, in early June. Just under two weeks later, the groundbreaking AI platform for liver cancer screening continued to create a buzz at the 2023 Extended Diagnostic Imaging Scientific Conference and was featured on VTV1 news.

What is interesting is that among several well-known and dominant healthcare technology companies in Vietnam, VinBrain is the only technology company showcasing AI intelligence products at the conference exhibition. This presence has attracted significant attention from both industry professionals and the media regarding the leadership and innovation in combining leading AI technology to address challenging diseases, particularly liver cancer. This cancer is considered prevalent, causing over 830,000 deaths globally each year and directly impacting Vietnam, a country in an epidemiological area for liver diseases, including dangerous conditions like hepatitis and cirrhosis.

VTV television emphasized that DrAid™ CT Liver Cancer is a technological advancement from Vietnam in applying artificial intelligence to healthcare. In terms of research and development, this software is built by Vietnamese developers and has been applied in many countries worldwide, including the United States.

In the age of technological advancements transforming human life, DrAid™ CT Liver Cancer is a leading Vietnamese AI solution, currently the only solution globally for liver cancer. It brings expectations of helping doctors accurately diagnose abnormal liver tumors, facilitating early diagnosis and treatment, increasing survival rates, and, in the best cases, achieving complete recovery for patients.

AI technology with big data and deep learning will enhance the accuracy in liver cancer detection, providing an effective treatment direction and giving a chance at life to patients facing this challenging disease in Vietnam and around the world.